Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;99(6):1275-1279.
doi: 10.1016/j.kint.2021.04.007. Epub 2021 Apr 20.

Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy

T Alp Ikizler  1 , P Toby Coates  2 , Brad H Rovin  3 , Pierre Ronco  4
Affiliations

Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy

T Alp Ikizler et al. Kidney Int. 2021 Jun.

Abstract

In this issue of Kidney International, the initial experience regarding the immunogenicity of prior coronavirus disease 2019 (COVID-19) infection and the response to the COVID-19 vaccines among patients on maintenance dialysis and kidney transplant recipients is summarized. Preliminary data suggest that there is durability of immune response after COVID-19 infection. Although immune response to the first dose of vaccine is less in infection-naïve patients than healthy individuals in both groups, after the second vaccine dose a significant portion of patients receiving maintenance dialysis develop robust antibody titers, whereas kidney transplant recipients show a less-strong immune response.

PubMed Disclaimer

Comment in

References

    1. Ng J.H., Hirsch J.S., Wanchoo R. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 2020;98:1530–1539. - PMC - PubMed
    1. Francis A., Baigent C., Ikizler T.A. The urgent need to vaccinate dialysis patients against severe acute respiratory syndrome coronavirus 2: a call to action. Kidney Int. 2021;99:791–793. - PMC - PubMed
    1. Clarke C.L., Prendecki M., Dhutia A. Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection. Kidney Int. 2021;99:1470–1477. - PMC - PubMed
    1. Forbes S., Davari M., Gnanasampanthan S. Persistence of antibody response to SARS-CoV-2 in a cohort of haemodialysis patients with COVID-19 [e-pub ahead of print]. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/gfab066 Accessed April 15, 2021. - DOI - PMC - PubMed
    1. Anft M., Blazquez-Navarro A., Paniskaki K. SARS-CoV-2–reactive cellular and humoral immunity in hemodialysis population. Kidney Int. 2021;99:1489–1490. - PMC - PubMed

Substances